venetoclax,rituximab,pirtobrutinib
roche,abbvie,eli lilly
['pirto', 'lymsm', 'bruin']
congress| #asco23 nirav shah reports on the updated results from the bruin study researching pirtobrutinib in patients with cbtki pre-treated r/r mcl. pirtobrutinib showed durable efficacy and a favorable safety profile. #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm